1. Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder.
- Author
-
Davis, Amber, Van Eck, Kathryn, Copeland-Linder, Nikeea, Phuong, Karen, and Belcher, Harolyn M.E.
- Subjects
- *
RESEARCH funding , *AUTISM , *HOSPITAL care , *HEALTH insurance , *RETROSPECTIVE studies , *LONGITUDINAL method , *ODDS ratio , *DOSE-effect relationship in pharmacology , *DISEASES , *COVID-19 , *ECONOMICS , *DISEASE complications - Abstract
Autism spectrum disorder (ASD) is a neuropsychiatric condition that may be associated with negative health outcomes. This retrospective cohort study reveals the odds of hospitalization and mortality based on ASD for a population of insured patients with COVID-19. The odds of hospitalization and mortality for people with ASD were found to be greater than individuals without ASD when adjusted for sociodemographic characteristics. Hospitalization and mortality was associated with a dose-response increase to comorbidity counts (1 to 5+). Odds of mortality remained greater for those with ASD when adjusting for comorbid health conditions. ASD is a risk factor for COVID-19 mortality. Comorbid health conditions play a particular role in increasing the odds of COVID-19 related hospitalization and death for ASD patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF